Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Koolen

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Circulation. Cardiovascular Interventions|December 25, 2009
Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2Bernard Chevalier, Sigmund Silber, Seung-Jung Park, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 2, 2011
Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trialSalvatore Brugaletta, Josep Gomez-Lara, Nico Bruining, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 29, 2014
Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical TrialChristos V Bourantas, Vasim Farooq, Yaojun Zhang, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 28, 2011
Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-studyJosep Gomez-Lara, Roberto Diletti, Salvatore Brugaletta, et al.
Atherosclerosis|January 3, 2012
Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque?Salvatore Brugaletta, Maria D Radu, Hector M Garcia-Garcia, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 26, 2012
Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segmentsSalvatore Brugaletta, Bill D Gogas, Hector M Garcia-Garcia, et al.
European Heart Journal|April 18, 2012
Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy?Salvatore Brugaletta, Jung Ho Heo, Hector M Garcia-Garcia, et al.
JACC. Cardiovascular Interventions|September 24, 2011
Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomographyJosep Gomez-Lara, Maria Radu, Salvatore Brugaletta, et al.
Circulation|November 25, 2010
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, John A Ormiston, et al.
JACC. Cardiovascular Interventions|December 24, 2011
Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomographyJosep Gomez-Lara, Salvatore Brugaletta, Vasim Farooq, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Circulation. Cardiovascular Interventions|December 25, 2009
Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2Bernard Chevalier, Sigmund Silber, Seung-Jung Park, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 2, 2011
Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trialSalvatore Brugaletta, Josep Gomez-Lara, Nico Bruining, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 29, 2014
Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical TrialChristos V Bourantas, Vasim Farooq, Yaojun Zhang, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 28, 2011
Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-studyJosep Gomez-Lara, Roberto Diletti, Salvatore Brugaletta, et al.
Atherosclerosis|January 3, 2012
Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque?Salvatore Brugaletta, Maria D Radu, Hector M Garcia-Garcia, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 26, 2012
Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segmentsSalvatore Brugaletta, Bill D Gogas, Hector M Garcia-Garcia, et al.
European Heart Journal|April 18, 2012
Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy?Salvatore Brugaletta, Jung Ho Heo, Hector M Garcia-Garcia, et al.
JACC. Cardiovascular Interventions|September 24, 2011
Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomographyJosep Gomez-Lara, Maria Radu, Salvatore Brugaletta, et al.
Circulation|November 25, 2010
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, John A Ormiston, et al.
JACC. Cardiovascular Interventions|December 24, 2011
Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomographyJosep Gomez-Lara, Salvatore Brugaletta, Vasim Farooq, et al.
Pageof 6